✦ LIBER ✦

470 Original regimen of subcutaneous interleukin 2 (IL2) and interferon alpha (IFN) in patients with metastatic renal cell carcinoma (MRCC) ineligible to receive intravenous (I.V.) IL2

✍ Scribed by B. Escudier; J.F. Rossi; A. Ravaud; J. Savary; K. Pignard; S. Négrier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

150 - Subcutaneous (SC) interleukin-2 (I

✍ J.M. Tourani; A. Benhammouda; P. Guillet; C. Pfister; B. Paule; J.F. Berbah; Y. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 262 KB

117 POSTER Activity of MVA 5T4 alone or

✍ R. Amato; A. Gary; A. Cao; J. Willis; M. McDonald; S. Naylor; R. Harrop; W. Shin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

MP-16.20: Thalidomide in combination wit

✍ R. Shiroki; S. Mori; S. Miyakawa; M. Ichino; M. Hirano; M. Kusaka; K. Hayakawa; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB